Tirofiban and activated protein c synergistically inhibit the Instant Blood Mediated Inflammatory Reaction (IBMIR) from allogeneic islet cells exposure to human blood

American Journal of Transplantation

Volumn 9, Issue 7, 2009, Pages 1533-1540

  Akima, S ^a   Hawthorne, W J ^a   Favaloro, E ^a   Patel, A ^a   Blyth, K ^a   Mudaliar, Y ^a   Chapman, J R ^a   O'Connell, P J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Coagulation; Inflammation; Islet transplantation

Indexed keywords

AGGROSTAT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; COMPLEMENT COMPONENT C4D; D DIMER; DROTRECOGIN; FIBRINOGEN; HEPARIN; LEUKOCYTE ELASTASE; POLYVINYLCHLORIDE; PROTEIN C; PROTEIN S; THROMBOPLASTIN; TIROFIBAN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ALLOGRAFT; ARTICLE; BLOOD CLOTTING; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; CELL COUNT; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; FIBRIN CLOT; GRAFT FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSTANT BLOOD MEDIATED INFLAMMATORY REACTION; LOW DRUG DOSE; NEUTROPHIL; PANCREAS ISLET CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOSIS;

ABO BLOOD-GROUP SYSTEM; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; INFLAMMATION; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTES; PERFUSION; PLATELET AGGREGATION INHIBITORS; PROTEIN C; RECOMBINANT PROTEINS; TRANSPLANTATION, HOMOLOGOUS; TYROSINE;

EID: 67649637126     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02673.x     Document Type: Article

References (22)

1. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230 238. (Pubitemid 30490390)
2. Shapiro AM, Ricordi C, Hering BJ et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006 355 : 1318 1330. (Pubitemid 44465460)
3. Moberg L, Johansson H, Lukinius A et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002 360 : 2039 2045. (Pubitemid 36026584)
4. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060 2069. (Pubitemid 40911269)
5. Ryan EA, Lakey JR, Paty BW et al. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 2002 51 : 2148 2157. (Pubitemid 34729020)
6. O'Connell PJ, Hawthorne WJ, Holmes-Walker DJ et al. Clinical islet transplantation in type 1 diabetes mellitus: Results of Australia's first trial. Med J Aust 2006 184 : 221 225.
7. Grey ST, Tsuchida A, Hau H, Orthner, CL, Salem HH, Hancock WW. Selective inhibitory effects of the anticoagulant activated protein C on the response of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol 1994 153 : 3664 3672. (Pubitemid 24313871)
8. Bernard GR, Vincent J-L, Laterre P-F et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001 344 : 699 709. (Pubitemid 32204987)
9. Contreras JL Eckstein C, Smyth CA et al. Activated protein C preserves functional islet mass after intraportal transplantation: A novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 2004 53 : 2804 2815.
10. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998 338 : 1498 1505.
11. Labinaz M, Madan M, O'Shea JO et al. Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy [ESPRIT] Trial). Am J Cardiol 2002 90 : 585 590. (Pubitemid 35264530)
12. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985 101 : 880 886. (Pubitemid 16256841)
13. Bennet W, Sundberg, B, Groth CG et al. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 1999 48 : 1907 1914. (Pubitemid 29458351)
14. Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: Possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 2002 51 : 1779 1784. (Pubitemid 34564290)
15. St Pierre J, Yang LY, Tamirisa K et al. Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs. Arterioscler Thromb Vasc Biol 1999 19 : 2263 2268. (Pubitemid 29422261)
16. Mohammed A, Mehrabani PA, Coombs R, Molesworth L, Favaloro EJ. The MDA-180 coagulation analyser: A laboratory evaluation. Pathology 1997 29 : 176 183. (Pubitemid 27296465)
17. Favaloro EJ, Henniker, A, Facey D, Hertzberg M. Discrimination of von Willebrands disease (VWD) subtypes: Direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems. Thromb Haemost 2000 84 : 541 547. (Pubitemid 30798930)
18. Moberg L, Korsgren, O, Nilsson B. Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood. Clin Exp Immunol 2005 142 : 125 131. (Pubitemid 41361015)
19. Fay PJ, Smudzin TM, Walker FJ. Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity. J Biol Chem 1991 266 : 20139 20145. (Pubitemid 21908437)
20. Theoret J-F, Bienvenu J-G, Kumar A, Merhi Y. P-Selectin antagonism with recombinant P-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces. J Pharmacol Exp Ther 2001 298 : 658 664. (Pubitemid 32673417)
21. Johansson H, Goto M, Dufrane D et al. Low molecular weight dextran sulfate: A strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 2006 6 : 305 312. (Pubitemid 43382165)
22. Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb 1992 12 : 135 145.